Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

UBS Maintains Buy on Ameriprise Finl, Lowers Price Target to $495

Author: Benzinga Newsdesk | July 09, 2024 04:29pm

UBS analyst Brennan Hawken maintains Ameriprise Finl (NYSE:AMP) with a Buy and lowers the price target from $500 to $495.

Posted In: AMP

08/02/2024 Humana Inc. (HUM)